Parnell Pharmaceuticals Holdings Ltd
PARN
PARN was delisted on the 30th of December, 2016.
15 hedge funds and large institutions have $11.5M invested in Parnell Pharmaceuticals Holdings Ltd in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 10 → 15 (+5)
11% more capital invested
Capital invested by funds: $10.4M → $11.5M (+$1.16M)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| 1 |
BlackRock
New York
|
+$13.7K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$6.84K |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$6.7K |
| 4 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
+$3.04K |
| 5 |
Morgan Stanley
New York
|
+$1.99K |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$119K |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$30.8K |
| 3 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$15.2K |
| 4 |
Goldman Sachs
New York
|
-$11.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $3.16M | – | – | – |
|
|
BA
2
BlackRock Advisors
Wilmington,
Delaware
| $2.18M | -$30.8K | -8,100 | -1% |
|
|
AG
3
Artal Group
Luxembourg
| $1.94M | – | – | – |
|
|
ECM
4
Endurant Capital Management
San Mateo,
California
| $1.69M | +$6.7K | +1,761 | +0.4% |
|
|
BG
5
BlackRock Group
London,
United Kingdom
| $894K | – | – | – |
|
|
6
Alyeska Investment Group
Chicago,
Illinois
| $739K | -$119K | -31,393 | -14% |
|
|
7
BlackRock
New York
| $447K | +$13.7K | +3,600 | +3% |
|
|
BIM
8
BlackRock Investment Management
Wilmington,
Delaware
| $343K | -$15.2K | -4,000 | -4% |
|
|
9
Goldman Sachs
New York
| $131K | -$11.2K | -2,941 | -8% |
|
|
LTFS
10
Ladenburg Thalmann Financial Services
Miami,
Florida
| $7K | +$6.84K | +1,800 | New |
|
|
11
UBS Group
Zurich,
Switzerland
| $4K | -$9.88K | -2,598 | -71% |
|
|
AA
12
AlphaMark Advisors
Ft. Wright,
Kentucky
| $3K | +$3.04K | +800 | New |
|
|
13
Morgan Stanley
New York
| $2K | +$1.99K | +523 | New |
|
14
Walleye Trading
New York
| $1K | +$761 | +200 | New |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| $1K | +$1.14K | +300 | New |
|
PARN Hedge Fund Activity: Q4 2015 in Review
15 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q4 2015, worth a combined $11.5M — up 11% from $10.4M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PARN positions and 0 closed out — a net gain of 5 holders — while 2 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $13.7K. The largest seller was Alyeska Investment Group, cutting an estimated $119K.
- 15 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q4 2015, up from 10 in Q3 2015.
- Funds reported $11.5M of Parnell Pharmaceuticals Holdings Ltd stock for Q4 2015, up 11% quarter-over-quarter.
- 5 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q4 2015 and 0 closed out, a net change of +5 holders.
- The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q4 2015 was BlackRock, an estimated $13.7K added.
- The largest Parnell Pharmaceuticals Holdings Ltd seller in Q4 2015 was Alyeska Investment Group, an estimated $119K sold.
Based on aggregated 13F filings for Q4 2015.